Dermatix Scar Treatment Gel, 15 g

Product Information

Introducing our advanced Silicone Scar Gel, the perfect solution for preventing scars on freshly healed wounds. Improvement in scarring in a 25-year-old woman undergoing lower eyelid surgery treated with Dermatix Ultra silicone gel (case 5). Unfortunately we are no longer able to send to France, Germany, Norway, Slovakia or Sweden due to customs regulations. which allows anyone to copy, distribute, and transmit the article provided it is properly attributed in the manner specified below.

Improvement in caesarean section scar in a 30-year-old woman following application of Dermatix Ultra silicone gel from 2 weeks post-surgery for 6 months (case 9). The product is generally safe for use in adults and children and should also not cause any issues for women who are pregnant, trying to become pregnant or who are breastfeeding but consult with your doctor before use.Hypertrophic scars and keloids develop following abnormal fibrous wound healing due to aberrant regulation of tissue repair and regeneration. This product is a medicine; make sure to speak to your doctor or Chemist 4 U pharmacist before taking this product if you have an underlying medical problem or are taking any other medicine or complementary therapy. Dermatix has been shown to flatten, soften and smooth scars, relieve the itching and discomfort of scarring as well as reduce the discoloration associated with scars.

Topical silicone gel versus placebo in promoting the maturation of burn scars: a randomized controlled trial. Please note that for prospective purchasers of aesthetic treatments, information and guidance provided does not substitute an in-depth consultation with an experienced practitioner. A specialist in burns and plastic surgery recommended starting treatment as early as possible in patients with burn wounds, within 7 days after the injury, and continuation for 3 months. If wounds were in a good condition, treatment could be started as soon as the wound could safely come into contact with water (7–10 days).Limitations of this study include the small number of cases ( n=11) and expert clinicians surveyed ( n=9) and the absence of objective effectiveness outcomes.